Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
906.2 USD | +1.34% | -3.23% | +3.15% |
03:58pm | UBS Adjusts Regeneron Pharmaceuticals Price Target to $1,099 From $1,090, Maintains Buy Rating | MT |
03:20pm | The market is pinning its hopes on earnings reports |
- Stock Market
- Equities
- REGN Stock
- News Regeneron Pharmaceuticals, Inc.